<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02636829</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2015/ET-01</org_study_id>
    <secondary_id>2015-A01033-46</secondary_id>
    <nct_id>NCT02636829</nct_id>
  </id_info>
  <brief_title>Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis</brief_title>
  <acronym>QALCIMUM</acronym>
  <official_title>Validation of Self-administered Questionnaire Specifically for Assessing Calcium Intake (QALCIMUM®) in Patients With Multiple Sclerosis (MS) or Chronic Inflammatory Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to measure, in patients with MS or Chronic Inflammatory&#xD;
      Arthritis (CIA), the correlation between two calcium intake assessment methods: A self&#xD;
      assessment questionnaire of calcium intake (QALCIMUM®) versus a food survey serving as a&#xD;
      reference (gold standard) and based on data from CIQUAL *.&#xD;
&#xD;
      * CIQUAL Data: Nutritional food composition table available on the website of the ANSES&#xD;
      (National Agency for Sanitary Security of Food, Environment and Labour), published by the&#xD;
      Observatory of the Nutritional Quality of Foods. This table includes 1500 sheets of 58&#xD;
      nutritional components. The data is integrated into the software (DATAMEAL) for calculating&#xD;
      the ingesta parameters at the Nîmes University Hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are:&#xD;
&#xD;
      A. To estimate the average calcium intake and variability in a population of MS patients and&#xD;
      the proportion of patients at risk for osteoporosis.&#xD;
&#xD;
      B. To estimate the average calcium intake and variability in a population of CIA patients and&#xD;
      the proportion of patients at risk for osteoporosis.&#xD;
&#xD;
      C. To describe the dietary changes observed in MS or CIA patients .&#xD;
&#xD;
      D. To estimate the administration time of the QALCIMUM® self-questionnaire.&#xD;
&#xD;
      E. Estimate calcium intake means and variability in a population of patients with MS or CIA&#xD;
      and the proportion of patients at risk of osteoporotic fracture&#xD;
&#xD;
      F. To assess the quality of life of patients with MS or CIA&#xD;
&#xD;
      G. To evaluate endogenous mean vitamin D production in a population of patients with MS or&#xD;
      CIA&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calcium intake (mg/day)</measure>
    <time_frame>Day 0</time_frame>
    <description>As determined by a consultation with a dietician.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The QALCIMUM questionnaire</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient diet (qualitative)</measure>
    <time_frame>Day 0</time_frame>
    <description>Patient diet classified as: normal; vegetarian, vegetalian; Seignalet; Kousmine; other.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QALCIMUM questionnaire administration time (minutes)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The GRIO questionnaire</measure>
    <time_frame>Day 0</time_frame>
    <description>GRIO = Osteoporosis Research and Information Group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The FRAX questionnaire</measure>
    <time_frame>Day 0</time_frame>
    <description>FRAX = WHO Fracture RISK Assessment Tool</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire: MSIS29 (MS Impact Scale)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire: TLSQOL10</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire: TLS Coping</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Vitamin D questionnaire</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Multiple Sclerosis patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (Multiple Sclerosis, Rheumatoid Arthritis) will be recruited during specialized consultations or hospital admissions for monitoring their chronic disease at the University Hospital of Nimes and will be divided into two distinct groups.&#xD;
Intervention: QALCIMUM questionnaire&#xD;
Intervention: Determination of calcium intake by a dietician interview</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rheumatoid Arthritis patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (Multiple Sclerosis, Rheumatoid Arthritis) will be recruited during specialized consultations or hospital admissions for monitoring their chronic disease at the University Hospital of Nimes and will be divided into two distinct groups.&#xD;
Intervention: QALCIMUM questionnaire&#xD;
Intervention: Determination of calcium intake by a dietician interview</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>QALCIMUM questionnaire</intervention_name>
    <description>All patients will fill out the QALCIMUM questionnaire.</description>
    <arm_group_label>Multiple Sclerosis patients</arm_group_label>
    <arm_group_label>Rheumatoid Arthritis patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Determination of calcium intake by a dietician interview</intervention_name>
    <description>All patients will have an interview with a dietician who performs a food survey serving as a reference (gold standard) and based on data from CIQUAL *.&#xD;
* CIQUAL Data: Nutritional food composition table available on the website of the ANSES (National Agency for Sanitary Security of Food, Environment and Labour), published by the Observatory of the Nutritional Quality of Foods. This table includes 1500 sheets of 58 nutritional components. The data is integrated into the software (DATAMEAL) for calculating the ingesta parameters at the Nîmes University Hospital.</description>
    <arm_group_label>Multiple Sclerosis patients</arm_group_label>
    <arm_group_label>Rheumatoid Arthritis patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient must have given his/her informed and signed consent&#xD;
&#xD;
          -  The patient must be insured or beneficiary of a health insurance plan&#xD;
&#xD;
          -  Patient with confirmed diagnosis of multiple sclerosis or chronic inflammatory&#xD;
             arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is participating in another biomedical research study&#xD;
&#xD;
          -  The patient has participated in another biomedical research study in the past 3 months&#xD;
&#xD;
          -  The patient is in an exclusion period determined by a previous study&#xD;
&#xD;
          -  The patient is under judicial protection, or under guardianship&#xD;
&#xD;
          -  The patient refuses to sign the consent&#xD;
&#xD;
          -  It is impossible to correctly inform the patient&#xD;
&#xD;
          -  The subject is not able to complete a self-administered questionnaire&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Thouvenot, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>November 17, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <last_update_submitted>September 14, 2016</last_update_submitted>
  <last_update_submitted_qc>September 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

